IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q1 2026 Holdings

Filed 2026-05-06 | 16 holdings | $155.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$53.4M14,250,00034.3%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$38.0M7,058,65724.4%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$10.8M3,167,2316.9%
Tillys Inc(TLYS)CL A886885102$8.7M2,150,0005.6%
Outset MED Inc(OM)COM NEW690145206$7.3M1,902,2014.7%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$6.6M5,320,0004.2%
Carmax Inc(KMX)COM143130102$6.4M155,0004.1%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$5.3M720,7873.4%
Instil BIO Inc(TIL)COM NEW45783C200$5.3M645,6003.4%
Target Corp(TGT)COM87612E106$4.5M37,5002.9%
Kraft Heinz Co(KHC)COM500754106$2.8M125,0001.8%
Janux Therapeutics Inc(JANX)COM47103J105$2.2M154,9611.4%
Pliant Therapeutics Inc(PLRX)COM729139105$1.9M1,546,1371.3%
Connect Biopharma Hldgs LTD(CNTB)SHSG23549101$1.1M408,8870.7%
Imagenebio Inc(IMA)COM45175G207$1.0M200,7300.6%
Walmart Inc(WMT)PutPUT931142103$329.1K3350.2%